Recruiting OBSERVATIONAL NCT05012033

Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting (EHD-Pred PK)

Sponsor: Imperial College London

Conditions Asthma COPD Exacerbation Acute Inflammatory Disease Thyroid Eye Disease Vasculitis

Interventions No intervention - prednisolone is taken as part if routine clinical care.

Updated 4 times since 2021 Last updated: Sep 27, 2023 Started: Apr 12, 2023 Primary completion: Mar 26, 2026 Completion: Mar 26, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05012033, this observational or N/A phase trial focuses on Asthma and COPD Exacerbation Acute and remains actively recruiting participants. Sponsored by Imperial College London, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Oct 2023 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Sep 2021 — Oct 2023 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Imperial College London

Data source: Imperial College London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom